{
    "eid": "2-s2.0-85109391821",
    "title": "Levetiracetam dosing in patients receiving continuous renal replacement therapy",
    "cover-date": "2021-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "continuous renal replacement therapy",
        "critically ill patients",
        "drug dosing",
        "levetiracetam",
        "pharmacokinetics"
    ],
    "authors": [
        "Weerachai Chaijamorn",
        "Taniya Charoensareerat",
        "Dhakrit Rungkitwattanakul",
        "Sathian Phunpon",
        "Thanompong Sathienluckana",
        "Nattachai Srisawat",
        "Sutthiporn Pattharachayakul"
    ],
    "citedby-count": 1,
    "ref-count": 25,
    "ref-list": [
        "Levetiracetam: a review of its use in epilepsy",
        "Safety and efficacy of levetiracetam for critically ill patients with seizures",
        "Clinical pharmacokinetics of levetiracetam",
        "Pharmacokinetics of levetiracetam in patients with moderate to severe liver cirrhosis (Child-Pugh classes A, B, and C): characterization by dynamic liver function tests",
        "We underdose antibiotics in patients on CRRT",
        "Antibiotic dosing in continuous renal replacement therapy",
        "Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients",
        "Extracorporeal clearance of levetiracetam during continuous venovenous hemofiltration in a critically Ill Patient And New Dosing Recommendation",
        "Levetiracetam pharmacokinetics during continuous venovenous hemofiltration and acute liver dysfunction",
        "Levetiracetam pharmacokinetics in a patient receiving continuous venovenous hemofiltration and venoarterial extracorporeal membrane oxygenation",
        "Levetiracetam pharmacokinetics in a patient with intracranial hemorrhage undergoing continuous veno-venous hemofiltration",
        "A practice-based, clinical pharmacokinetic study to inform levetiracetam dosing in critically Ill patients undergoing continuous venovenous hemofiltration (PADRE-01)",
        "Antiepileptic dosing for critically ill adult patients receiving renal replacement therapy",
        "Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy",
        "Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy",
        "Use of monte carlo simulations to determine optimal carbapenem dosing in critically Ill patients receiving prolonged intermittent renal replacement therapy",
        "Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study",
        "Meropenem dosing recommendations for critically ill patients receiving continuous renal replacement therapy",
        "Acute renal failure in critically ill patients: a multinational, multicenter study",
        "Drug dosing in continuous renal replacement therapy: general rules",
        "KDIGO Clinical Practice Guideline for Acute Kidney Injury",
        "Management of renal replacement therapy in ICU patients: an international survey",
        "Pharmacokinetic profile of levetiracetam: toward ideal characteristics",
        "Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society"
    ],
    "affiliation": [
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022183",
            "affilname": "King Chulalongkorn Memorial Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60022182",
            "affilname": "Siam University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022182",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Washington, D.C.",
            "@id": "60012771",
            "affilname": "Howard University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012771",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hatyai",
            "@id": "60006314",
            "affilname": "Prince of Songkla University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006314",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Pittsburgh",
            "@id": "60001361",
            "affilname": "University of Pittsburgh School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60001361",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "101823394",
            "affilname": "Royal Society of Thailand",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/101823394",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": []
}